Special features of the CHARGE consortium are the large overall sample size, the population-based recruitment of cohort members, the standardized methods of data collection, and the prospective follow-up for clinical events. In case-control studies, it is not usually possible to obtain DNA from fatal cases. With the cohort design, DNA is generally available for all events, including the fatal ones; and failure-time models are recommended for associations with incident disease.
